Fulminant hepatic failure secondary to hydroxychloroquine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8175002.
- Also identified by PMC identifier 1374814.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hydroxychloroquine is widely used in rheumatological disease but hepatic side effects have not been reported previously. Two cases are described of fulminant hepatic failure developing after the start of hydroxychloroquine treatment for a chronic rheumatological disorder. In both cases the symptoms of liver disease developed within two weeks of starting hydroxychloroquine and rapidly progressed to fulminant hepatic failure and in neither case was there any pre-existing liver disease. One patient had emergency orthotopic liver transplantation and the other died before a donor organ became available.
Medical subject headings
- Hepatic Encephalopathy
- Hydroxychloroquine